Author(s): Dr. Lakshmi GL, Dr. Anilitta Sebastian and Dr. C Soma Sureshan
Abstract: Among symptomatic patients of COVID-19 infection, a few are in high-risk category having several co-morbidities. Type II Diabetes is one of the co-morbidities which show complications and mortality during COVID-19 infection. Also some Non-Diabetic patients are showing Hyperglycemia after they are diagnosed with COVID-19 infection. This article summarizes the pathophysiology and management of Hyperglycemia during and after COVID -19 infection.